Intra-amniotic administration of prostaglandin F 2   for induction of therapeutic abortion. A comparison of four dosage schedules.
D000032:Abortion, Therapeutic; D000293:Adolescent; D000328:Adult; D000653:Amniotic Fluid; D004305:Dose-Response Relationship, Drug; D005260:Female; D005865:Gestational Age; D006801:Humans; D008614:Meperidine / Q000627:therapeutic use; D009325:Nausea / Q000139:chemically induced; D010146:Pain; D010298:Parity; D011247:Pregnancy; D011346:Prochlorperazine / Q000627:therapeutic use; D011398:Promethazine / Q000627:therapeutic use; D011453:Prostaglandins / Q000008:administration & dosage* / Q000009:adverse effects; D014839:Vomiting / Q000139:chemically induced
D011453:Prostaglandins; D008614:Meperidine; D011398:Promethazine; D011346:Prochlorperazine